R&D

News

Moderna completes next stage of UK R&D facility build

US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and th

News

Study finds trials of prescription DTx often lack ‘rigour’

A retrospective analysis of the clinical data supporting 20 FDA-approved prescription digital therapeutics has found that they often fail to apply rigorous standards of ev

News

BMS extends its position in ADCs with $180m Orum deal

Bristol-Myers Squibb has signed another deal to build its capabilities in antibody-drug conjugates for cancer, paying $100 million upfront to take control of an Orum Thera

News

Beam cuts one in five staffers to conserve cash

Gene-editing company Beam Therapeutics has shifted into reverse, slashing staff and R&D programmes after a period of expansion since its public debut in 2020.

R&D

One Health: The interconnection of animal and human health

There’s a tendency to overlook the fact that human health and animal health are closely intertwined.

News

UK Biobank study “will shape drug discovery”

A landmark study drawing on data from UK Biobank has generated a first-of-its-kind dataset of the interactions between genes and proteins that could unlock myriad avenues for research

Moderna completes next stage of UK R&D facility build

Study finds trials of prescription DTx often lack ‘rigour’

BMS extends its position in ADCs with $180m Orum deal

Beam cuts one in five staffers to conserve cash

One Health: The interconnection of animal and human health

UK Biobank study “will shape drug discovery”

AZ claims another win for Imfinzi in frontline liver cancer

Using AI-driven synthetic personas to take your insights fur...

R&D

Editor's Picks